Caribou Biosciences, Inc. Profile Avatar - Palmy Investing

Caribou Biosciences, Inc.

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead…

Biotechnology
US, Berkeley [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Caribou Biosciences, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Caribou Biosciences, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Caribou Biosciences, Inc..

End of CRBU's Analysis
CIK: 1619856 CUSIP: 142038108 ISIN: US1420381089 LEI: - UEI: -
Secondary Listings
CRBU has no secondary listings inside our databases.